Presentation TCT 2025 TCT 470: Comparative Outcomes of Serum LDL Levels <55 mg/dL Versus 55–100 mg/dL for Primary Prevention of Undiagnosed Coronary Artery Disease: A Retrospective Cohort Study Presenter: Mehmet Cilingiroglu October 27, 2025
Presentation TCT 2025 TCT 474: Edoxaban Monotherapy for Atrial Fibrillation and Stable Coronary Artery Disease in Diabetic Patients: The EPIC-CAD Trial Presenter: Seunghan Lee October 27, 2025
Presentation TCT 2025 TCT 472: Prognostic effect of insulin resistance in patients with moderate-to-severe coronary artery calcification: a prospective cohort study Presenter: Zixiang Ye October 27, 2025
Presentation TCT 2025 TCT 471: Pericoronary Fat Attenuation Index Combined with Lp(a) for Predicting Post-PCI Adverse Outcomes in Coronary Artery Disease Patients Presenter: Zixiang Ye October 27, 2025
Presentation TCT 2025 TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study Presenter: Kunal Mahajan October 27, 2025
Presentation TCT 2025 Multi-Organ Ethanol Denervation to Treat Type 2 Diabetes Mellitus and Hypertension: 6-Month Results of an Early Feasibility Study Presenter: Ajay J. Kirtane October 27, 2025
Presentation TCT 2025 TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database Presenter: Aymen Ahmed October 26, 2025
Presentation TCT 2025 TCT 775: Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database Presenter: Aymen Ahmed October 26, 2025
Presentation TCT 2025 TCT 208: Multi-Organ Arterial Denervation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities (NECTAR IV Trial) Presenter: Horst Sievert October 26, 2025
Presentation TCT 2025 TCT 681: Impact of Intravascular Imaging-Guided Drug-Eluting Stent Implantation on Cardiac Mortality in Patients with Diabetes and Coronary Artery Disease: A Multicenter Cohort Study Presenter: Xiaofei Gao October 26, 2025
Presentation TCT 2025 TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis Presenter: Mahsa Rezasoltani October 26, 2025
Presentation TCT 2025 TCT 748: Effects of SGLT2 Inhibitors on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus Undergoing Transcatheter Mitral Valve Repair: A Propensity-Matched Analysis Presenter: Mahmoud Abdelnabi October 25, 2025
Presentation TCT 2025 TCT 749: Renal Protective Effects of SGLT2 Inhibitors After Transcatheter Mitral Valve Repair in Patients with Type 2 Diabetes Mellitus: A Propensity-Matched Retrospective Analysis Presenter: Mahmoud Abdelnabi October 25, 2025
Presentation TCT 2025 Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study Presenter: Alexandre Abizaid October 25, 2025
News Daily News Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Caitlin E. Cox October 22, 2025
News Daily News Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health? L.A. McKeown October 17, 2025
News Daily News Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients Caitlin E. Cox October 16, 2025
News Daily News Elderly CABG Patients Stand to Benefit From Artery-Only Strategy Caitlin E. Cox October 13, 2025
News Daily News High Aerobic Fitness Linked to Less Chronic Disease in Later Life Michael O'Riordan October 10, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025